Outset Medical (OM)
Nasdaq Market Closed
Outset Medical, Inc. is a medical technology company that develops dialysis systems intended to make treatment simpler to deliver across different care settings. Its core product is Tablo, a haemodialysis platform designed to combine water purification, on-demand dialysate production, touchscreen guidance, and treatment monitoring in a single system. The company’s technology is aimed at reducing the operational complexity traditionally associated with dialysis infrastructure.
Outset Medical sells Tablo consoles and recurring consumables, including cartridges and related accessories used during treatment. The company serves hospitals, health systems, and providers involved in acute and chronic dialysis care, with a particular focus on enabling treatment in more flexible environments. By simplifying setup and workflow, Tablo is designed to support clinicians while also expanding the potential for home-based or decentralised dialysis models where clinically appropriate.
The company operates in a highly regulated healthcare market where purchasing decisions depend on clinical performance, reliability, reimbursement dynamics, training needs, and the economics of care delivery. Dialysis is a large and essential area of treatment for patients with kidney failure, but it is also associated with significant costs and operational demands. Outset Medical’s investment case is closely linked to adoption of its platform, growth in installed systems, utilisation of its consumables, and its ability to demonstrate value to providers seeking more efficient dialysis options. Competition includes established dialysis equipment manufacturers and broader healthcare technology suppliers.
Last updated
- Market Cap
- 74.52M
- P/E
- —
- P/FCF
- —
- P/S
- 0.63
- Enterprise Value
- 140.98M
- Sector
- Industrials
- Industry
- Electromedical and Electrotherapeutic Apparatus
- Address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
No recent news is linked to this listing.
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 74.52M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 140.98M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.67
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.63
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -2.22
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.2
- EPS
- -4.04
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -34.25M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -67.02%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -30%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.87
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 6.29
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 4.97
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.81
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 193.88K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 4.02
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 27.86M | 28.87M | 29.43M | 31.42M | 29.75M |
| Gross profit | 12.1M | 12.23M | 11.59M | 11.87M | 11.07M |
| Operating income | -16.92M | -17.63M | -15.81M | -16.87M | -16.4M |
| EBITDA | -16.12M | -16.75M | -14.8M | -15.71M | -15.11M |
| Net income | -18.98M | -19.49M | -17.84M | -18.54M | -25.78M |
| Basic EPS | -1.03 | -1 | -1 | -1.04 | -3.66 |
| Diluted EPS | -1.03 | -1 | -1 | -1.04 | -3.66 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 249.45M | 264.5M | 277.26M | 288.8M | 301.21M |
| Total liabilities | 137.77M | 137.54M | 134.89M | 134.02M | 131.34M |
| Total equity | 111.69M | 126.95M | 142.37M | 154.78M | 169.87M |
| Cash & equivalents | 30.56M | 35.01M | 36.44M | 39.56M | 75.93M |
| Current assets | 236.71M | 250.88M | 265.37M | 275.58M | 286.56M |
| Current liabilities | 37.61M | 37.63M | 37.45M | 36.91M | 34.22M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -12.84M | -9.52M | -6.32M | -4.82M | -25.66M |
| Investing cash flow | 7.9M | 8.59M | 2.97M | -31.16M | -78.08M |
| Financing cash flow | 501K | 0 | 231K | -384K | 55.66M |
| Change in cash | -4.44M | -931K | -3.12M | -36.37M | -48.09M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Drexler Karen | View Filing | |
| form 4 | Form 4 — Drexler Karen | View Filing | |
| form 4 | Form 4 — GROSSMAN D KEITH | View Filing | |
| form 4 | Form 4 — GROSSMAN D KEITH | View Filing | |
| form 4 | Form 4 — LANG BRENT D. | View Filing | |
| form 4 | Form 4 — LANG BRENT D. | View Filing | |
| form 4 | Form 4 — Prange Karen | View Filing | |
| form 4 | Form 4 — OBOYLE KEVIN C | View Filing | |
| form 4 | Form 4 — HACKETT PATRICK T | View Filing | |
| form 4 | Form 4 — HACKETT PATRICK T | View Filing | |
| form 4 | Form 4 — HACKETT PATRICK T | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Gaeta Renee | View Filing | |
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| edgar index | SD — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Brottem John L. | View Filing | |
| form 4 | Form 4 — Nash Marc | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| form 4 | Form 4 — Leonard Braden Michael | View Filing | |
| edgar index | 8-K — Outset Medical, Inc. | View Filing | |
| edgar index | 10-Q — Outset Medical, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Outset Medical, Inc. | View Filing | |
| edgar index | DEFA14A — Outset Medical, Inc. | View Filing | |
| edgar index | 3 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Elliott Derick A. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 3/A — Outset Medical, Inc. | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| form 3 | Form 3 — Leonard Braden Michael | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | 4 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | 144 — Outset Medical, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Outset Medical, Inc. | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Trigg Leslie | View Filing | |
| form 4 | Form 4 — Brottem John L. | View Filing | |
| form 4 | Form 4 — Nash Marc | View Filing | |
| edgar index | 10-K — Outset Medical, Inc. | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free